Alerts will be sent to your verified email
Verify EmailAMERISE
|
Amerise Biosciences
|
Siddha Ventures
|
Premium Cap Mkt&Inv
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
1.97 % | 14.11 % | 57.07 % |
|
5yr average Equity Multiplier
|
1.37 | 1.01 | 0.05 |
|
5yr Average Asset Turnover Ratio
|
0.15 | 0.01 | 2.1 |
|
5yr Avg Net Profit Margin
|
1.22 % | 339.31 % | -290.86 % |
|
Price to Book
|
0.75 | 0.12 | 0.0 |
|
P/E
|
68.07 | 0.0 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | 0.0 | 24.57 Days |
|
Inventory Days
|
0.0 | 3226.25 Days | 19.17 Days |
|
Days Receivable
|
0.0 | 0.0 | 3.89 Days |
|
Days Payable
|
27.62 Days | 0.0 | 14.82 Days |
|
5yr Average Interest Coverage Ratio
|
-378.51 | 2057.07 | -329.32 |
|
5yr Avg ROCE
|
-0.34 % | 13.3 % | -11.7 % |
|
5yr Avg Operating Profit Margin
|
-0.04 % | 340.7 % | -174.33 % |
|
5 yr average Debt to Equity
|
0.01 | 0.0 | -0.01 |
|
5yr CAGR Net Profit
|
n/a | n/a | 31.95 % |
|
5yr Average Return on Assets
|
-1.23 % | 13.17 % | -46.06 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.0 | 5.76 % | 24.25 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -19.01 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Amerise Biosciences
|
Siddha Ventures
|
Premium Cap Mkt&Inv
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|